about
Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAsThe genetic landscape of mutations in Burkitt lymphoma.Plasmacytoid dendritic cell nodules in bone marrow biopsies of chronic myelomonocytic leukemia.Bone marrow trephine biopsy findings in B acute lymphoblastic leukaemia of early precursor (Pro-B) subtype.Hypoplastic presentation of acute lymphoblastic leukemia.Estimation of cell density to aid in assessment of percentage cells of a particular lineage or of cells expressing a specific antigen in bone marrow trephine biopsies.Lymphomas in sub-Saharan Africa--what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research?The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: adipophilinConsolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need?Nodal marginal zone B-cell lymphoma with prominent follicular colonization - difficulties in diagnosis: a study of 15 cases.p27Kip1 and p130 cooperate to regulate hematopoietic cell proliferation in vivo.Benign metastasizing meningioma.Overlapping dose responses of spermatogenic and extragonadal testosterone actions jeopardize the principle of hormonal male contraceptionNo Evidence of XMRV or MuLV Sequences in Prostate Cancer, Diffuse Large B-Cell Lymphoma, or the UK Blood Donor Population.In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behaviorEBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors.Meeting the challenge of hematologic malignancies in sub-Saharan AfricaUse of the World Health Organization (WHO) classification of non-Hodgkin's lymphoma in Mumbai, India: a review of 200 consecutive cases by a panel of five expert hematopathologists.Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent diseaseGenetic heterogeneity of diffuse large B-cell lymphomaOptimal processing of bone marrow trephine biopsy: the Hammersmith Protocol.Cutaneous presentation of aleukemic monoblastic leukemia cutis - a case report and review of literature with focus on immunohistochemistry.Small intestinal presentation of nodular lymphocyte-predominant Hodgkin lymphoma with T cell/histiocyte-rich B cell lymphoma-like areas-with review of literature on extranodal presentation of this disease.Malignancies confined to disused arteriovenous fistulae in renal transplant patients: an important differential diagnosis.Diffuse large B cell lymphoma complicating total knee arthroplasty: case report and literature review of the association of diffuse large B cell lymphoma with joint replacement.Accelerated healing of cutaneous leishmaniasis in non-healing BALB/c mice using water soluble amphotericin B-polymethacrylic acid.Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2.Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma.DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphomaCD40 and B-cell receptor signalling induce MAPK family members that can either induce or repress Bcl-6 expression.Mutational landscape of B-cell post-transplant lymphoproliferative disorders.Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients.Bone marrow manifestations in multicentric Castleman disease.CD40 Ligand--an anti-apoptotic molecule in Hodgkin's disease.Establishment of a human squamous cell carcinoma cell line of the upper aero-digestive tract.Leucocyte common antigen (CD45) and CD5 positivity in an "undifferentiated" carcinoma: a potential diagnostic pitfall.Posttransplant lymphoproliferative disorders.The role of the microenvironment in human immunodeficiency virus-associated classical Hodgkin lymphoma.Atraumatic splenic rupture secondary to chronic HIV infection.Expression of enhancing factor/phospholipase A2 in skin results in abnormal epidermis and increased sensitivity to chemical carcinogenesis.
P50
Q24618086-02B746C7-47C3-427E-BF89-1ACD6E5D419DQ30453771-CB451265-8A58-42F1-9452-A76FC7A12414Q33392048-C2E02679-A4A4-41E8-AFCF-E7CE2E7F988BQ33393819-F9E92649-C66B-480A-A76B-42FD5ACCC92BQ33401464-A9CE2CB9-70A5-41DC-B658-BC60AB1FF447Q34037547-09BCF3EB-F6D9-4469-A20D-C9ED124D83D4Q34391704-7B304E38-14CC-40D7-813C-0F0D309F1679Q34406580-5A40CEBE-6D5D-43B0-AF7F-629C6AD515B3Q34543719-04F52D82-EC90-4CA7-A30A-B9EC6A82F0C6Q34749394-B0E639AF-46B2-4E24-83BB-D93E7AFEF355Q35071046-6EC16604-954C-49AA-9AA8-DD91DC44491EQ35082605-A2F92169-5506-4FAE-B30D-AA622471A558Q35224168-0712CD43-1CFF-41A6-AB27-2EF7E23D8EE3Q35692351-1FAA225D-F9EE-4A58-B454-B1033CCE9021Q35717870-C313858D-6B32-4985-8EB8-C45468AC951CQ35858022-0D4D8464-75F9-461A-AB67-0DFBA407EBFAQ35865085-14FC2103-6BCA-46D7-A54C-F17B9C63317BQ35888679-E251380D-939D-4945-B636-57CFFD505136Q36201443-EBEFE592-C6D4-416F-AFAB-2A962A6A5E83Q36567845-1C8EDD92-9EE5-43CB-BCC2-3A165C1D07B3Q36578968-F029460C-B8AA-49FE-8E3D-0A6352B45F7CQ37187818-B08CF361-583C-4D3C-A10C-447BF08A9757Q37857661-DFE5761F-BDD9-4279-85A8-B79044074A1CQ37887354-7E40BC33-0D23-4638-9B74-E1F7556649FEQ37898400-3093060D-EF56-4CDC-9A14-62571D21EBA9Q38342306-065AFB0D-1114-4DDB-BE3A-689FE7CEF288Q38692997-7C5A34EE-56B7-4AEA-9746-5104CA109C6AQ39264005-99CF4E78-C21D-4AAB-8C6E-B34DF1EF9C7BQ39692513-2FC3E64A-6C82-44F0-ABFA-F8DD35572431Q39875944-2EEF017A-DCF2-4FE6-AE12-96ABDDCEB66FQ40238236-08FAAB33-65FF-4484-87B8-C1986187FF0EQ40351293-39A3C598-3B52-419D-AF61-EB6568778CE2Q40815553-FC6E4498-D346-4233-839D-FDF17EFCFA38Q40816066-26737C47-8074-443B-ADC9-4AFE7B0C49B2Q41089675-5C62CAD5-F138-4174-9FB8-CA641A3FD597Q41384892-855D7D81-315D-4790-88C2-249608FC692EQ42137120-BD97690B-C67E-480E-A631-1253C06AE498Q42219900-5B9EAF9C-934D-435D-8175-F7D250A92142Q42274802-1F92F13F-C501-4532-99A1-5C70EB09C167Q42439190-F716102F-1AA9-4615-A942-500EB9B5932E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kikkeri N Naresh
@ast
Kikkeri N Naresh
@en
Kikkeri N Naresh
@es
Kikkeri N Naresh
@nl
Kikkeri N Naresh
@sl
type
label
Kikkeri N Naresh
@ast
Kikkeri N Naresh
@en
Kikkeri N Naresh
@es
Kikkeri N Naresh
@nl
Kikkeri N Naresh
@sl
prefLabel
Kikkeri N Naresh
@ast
Kikkeri N Naresh
@en
Kikkeri N Naresh
@es
Kikkeri N Naresh
@nl
Kikkeri N Naresh
@sl
P108
P106
P108
P1153
35515853400
P31
P496
0000-0003-3807-3638